Arcellx

Arcellx is a biopharmaceutical company developing next‑generation cell therapies for cancer and autoimmune diseases. With a proprietary technology platform, they aim to reimagine and "supercharge" cell therapy to pursue cures and improve patient outcomes. The company advances engineered cell therapy candidates through research and clinical development to address unmet medical needs. Arcellx emphasizes innovation in therapeutic design and clinical translation.